FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - Boerse Frankfurt Warrants 18:25:18 10/05/2024 BST | ||
| 3.6 EUR | +0.56% |
|
| Current month | -40.10% | ||
| 1 month | -45.62% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/05/24 | 3.6 | +0.56% | 0 |
| 09/05/24 | 3.58 | -9.60% | 0 |
| 08/05/24 | 3.96 | -3.18% | 0 |
| 07/05/24 | 4.09 | -0.49% | 0 |
| 06/05/24 | 4.11 | +16.76% | 0 |
Real-time Boerse Frankfurt Warrants
Last update May 10, 2024 at 06:25 pm
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UM0H6V |
| ISIN | DE000UM0H6V3 |
| Date issued | 04/01/2024 |
| Strike | 417.1 $ |
| Maturity | Unlimited |
| Parity | 26.56 : 1 |
| Emission price | 5.1 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.91 € |
|---|---|
| Lowest since issue | 3.1 € |
| Spread | 0.1 € |
| Spread % | 2.66% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
314.6
USD
Spread / Average Target
+1.45%
- Stock Market
- Certificates
- Certificat
